Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Tyra Biosciences, Inc. (TYRA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 41,270,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Tyra Biosciences is an oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Co. is focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor, or FGFR family. Co.'s lead product candidate, TYRA-300, is designed to selectively inhibit Fibroblast Growth Factor Receptor3, with an initial focus on patients with bladder cancer. In addition, Co. has pipeline development programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during Transfection kinase, and FGFR4-related cancers.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,298 221,691 456,290 785,314
Total Sell Value $427,399 $3,766,874 $7,701,881 $12,216,507
Total People Sold 1 2 2 3
Total Sell Transactions 10 15 38 53
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 135
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Hudkins Robert L. Chief Technology Officer   •       –      –    2022-09-15 4 A $7.66 $7,965 D/D 1,040 273,576     -
   Tada Hiroomi Chief Medical Officer   •       –      –    2022-03-15 4 A $8.53 $23,044 D/D 2,703 80,625     -
   Harris Todd Chief Executive Officer   •       •      –    2022-03-15 4 A $8.53 $26,642 D/D 3,125 1,699,468     -
   Patel Piyush R. Chief Development Officer   •       –      –    2022-03-15 4 A $8.53 $20,529 D/D 2,408 137,472     -
   Swanson Ronald V. Chief Scientific Officer   •       –      –    2022-03-15 4 A $8.53 $26,642 D/D 3,125 273,254     -
   Hudkins Robert L. Chief Technology Officer   •       –      –    2022-03-15 4 A $8.53 $20,529 D/D 2,408 272,536     -
   Van Den Boom Esther Chief Financial Officer   •       –      –    2022-03-15 4 A $8.53 $15,346 D/D 1,800 120,445     -
   Lewis Joseph 10% Owner   –       –       •   2021-12-17 4 B $13.12 $1,640,313 D/D 125,000 6,448,359 2.45     -
   Cormorant Private Healthcare Fund Iii Lp Former 10% Owner   –       –      –    2021-09-17 4 B $16.00 $5,000,000 I/I 312,500 1,069,932 0.01     -
   Cormorant Private Healthcare Fund Iii Lp Former 10% Owner   –       –      –    2021-09-17 4 A $0.00 $0 I/I 757,432 757,432     -
   Canaan Partners 2020+ Co-Investment Llc 10% Owner   –       –       •   2021-09-17 4 A $0.00 $0 D/D 4,409,991 473,396     -
   More Robert J Director   –       •      –    2021-09-17 4 B $16.00 $2,500,000 I/I 156,250 4,080,296 2.1     -
   More Robert J Director   –       •      –    2021-09-17 4 A $0.00 $0 I/I 3,811,117 3,924,046     -
   Davis Aaron I. 10% Owner   –       –       •   2021-09-17 4 A $0.00 $0 D/D 5,986,454 288,095     -
   Davis Aaron I. 10% Owner   –       –       •   2021-09-17 4 B $16.00 $10,000,000 D/D 625,000 6,323,359 2.45     -
   Bensen Daniel Chief Operating Officer   •       –      –    2021-09-17 4 A $0.00 $0 D/D 8,501 527,981     -
   Janney Daniel 10% Owner   –       –       •   2021-09-17 4 B $16.00 $2,500,000 I/I 156,250 4,080,296 1.5     -
   Janney Daniel 10% Owner   –       –       •   2021-09-17 4 A $0.00 $0 I/I 3,811,117 3,924,046     -
   Harris Todd Chief Executive Officer   •       •      –    2021-09-17 4 A $0.00 $0 D/D 34,007 1,696,343     -
   Van Den Boom Esther Chief Financial Officer   •       –      –    2021-09-17 4 A $0.00 $0 I/I 21,254 21,254     -
   Chen Isan Director   –       •      –    2021-09-17 4 A $0.00 $0 D/D 61,444 192,783     -
   Kjellson Nina S Director   –       •      –    2021-09-17 4 A $0.00 $0 I/I 4,409,991 473,396     -
   Shah Rajeev M. Director   –       •       •   2021-09-17 4 A $0.00 $0 I/I 5,986,454 442,721     -
   Shah Rajeev M. Director   –       •       •   2021-09-17 4 B $16.00 $20,000,000 I/I 1,250,000 5,297,120 2.25     -
   More Robert J Director   –       •       •   2021-09-14 3 IO $0.00 $0 I/I 0 112,929     -

  135 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed